Sex Differences in Dementia: Men Exhibit 24% Increased Mortality Risk

A comprehensive study uncovers that men with dementia have a 24% higher risk of mortality and increased healthcare utilization compared to women, highlighting important sex-specific differences in dementia outcomes.
Recent research led by Duke University School of Medicine reveals notable differences in how dementia impacts men and women. The study, published in JAMA Neurology, analyzed Medicare data from 2014 to 2021, involving over 5.7 million patients aged 65 and older diagnosed with dementia. Findings indicate that male patients with dementia face a 24% higher risk of death compared to female patients, even after adjusting for various factors. Additionally, men tend to have higher rates of hospitalizations, neuroimaging, and behavioral health-related hospital stays. Conversely, women generally experience faster cognitive decline and a higher incidence of dementia globally, with cardiovascular and metabolic factors influencing their risk more significantly. The disparities in mortality are likely driven more by the increased incidence of dementia among women rather than higher mortality rates post-diagnosis in women. The study highlights the importance of understanding sex-specific factors in dementia care and emphasizes that tailored approaches could improve outcomes across populations.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Study Reveals Blood Biomarkers Linked to Chronic Fatigue Syndrome
A pioneering study has identified consistent blood biomarkers associated with ME/CFS, supporting improved diagnosis and understanding of the illness’s biological basis.
The Hidden Cardiovascular Risks of Wildfire Smoke Extending Beyond Fire Zones
Wildfire smoke extends its health threat beyond fire zones, increasing the risk of heart attacks and cardiovascular events even in regions far from the fires. Learn how to protect your heart health during wildfire seasons.
New Molecule PA-915 Demonstrates Promising Long-Lasting Antidepressant Effects in Mice Without Common Side Effects
A new molecule named PA-915 has demonstrated significant, long-lasting antidepressant effects in mice without common side effects, offering promising potential for treating depression and anxiety disorders.
Innovative Autoinjector Promises Rapid Treatment for Severe Bleeding Emergencies
A groundbreaking autoinjector delivers lifesaving tranexamic acid within five minutes, enhancing emergency response in severe bleeding cases by providing fast, easy-to-administer treatment outside hospital settings.